Scaffold Technology Market by Product Type (Natural Scaffold and Synthetic Scaffold), by Type (Macro-porous Scaffolds, Micro-porous Scaffolds, Nano-porous Scaffolds, Solid Scaffolds), Application (Cancer Cell Research, Stem Cell Research, Drug Discovery, Regenerative Medicine, and Others), and End User (Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global scaffold technology market was valued at $1,930.37 million in 2019, and is projected to reach $7,522.33 million by 2027, registering a CAGR of 18.3% from 2019 to 2027.
Cell culture is a significant tool in biological research. It is mainly of two types, two-dimensional (2D) and three-dimensional (3D). Since the advent of cell culture techniques, 2D cell cultures are mostly preferred due to their availability, ease of environmental control, cell observation, and measurement. However, growing cells in flat layers on surfaces do not precisely model the in-vivo state. As compared to 2D, 3D cell culture permits the biological cells to grow and interact with their surroundings in all three dimensions. Scaffolds are 3D porous and fibrous biomaterials that promote cell interaction, viability, and extracellular matrix (ECM) deposition with minimum inflammation and toxicity.
The growth of the global scaffold technology market is majorly driven by rise in demand for body reconstruction procedures and tissue engineering, increase in usage of biomaterials, and growth of technological advancement of scaffold technology. However, high costs associated with implementation and emergence of scaffold-free technology for cell culturing are expected to hamper the growth of the market. On the contrary, increase in expenditure on R&D by governments in developing countries has high growth potential in these countries.
The scaffold technology market is segmented on the basis of product type, type, application, end user, and region. Based on product type, the scaffold technology market is divided into natural scaffold and synthetic scaffold. On the basis of type, it is divided into macro-porous scaffolds, micro-porous scaffolds, nano-porous scaffolds, and solid scaffolds. By application, it is fragmented into cancer cell research, stem cell research, drug discovery, regenerative medicine, and others. By end user, it is classified into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS - This report entails a detailed quantitative analysis along with the current global scaffold technology market trends from 2020 to 2027 to identify the prevailing opportunities along with the strategic assessment.
- The scaffold technology market forecast is studied from 2020 to 2027.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product Type • Natural Scaffold
• Synthetic Scaffold
By Type • Macro-porous Scaffolds
• Micro-porous Scaffolds
• Nano-porous Scaffolds
• Solid Scaffolds
By Application • Cancer Cell Research
• Stem Cell Research
• Drug Discovery
• Regenerative Medicine
By End User • Biotechnology & Pharmaceutical Companies
• Contract Research Laboratories
• Academic Institutes
By Region • North America
o Rest of Europe
o Rest of Asia-Pacific
o South Africa
o Saudi Arabia
o Rest of LAMEA
KEY MARKET PLAYERS • 3D Biotek LLC
• Advanced Biomatrix, Inc.
• Agilent Technologies, Inc. (Biotek)
• BioVison, Incorporated
• Corning Incorporated
• Merck KGaA (Sigmaaldrich)
• PromoCell GmbH
• Reprocell, Incorporation
• Synthecon, Incorporated
• Thermo Fisher Scientific Inc.
Our reports have been used by over 10K customers, including:
The global single-use assemblies market is projected to reach USD 6.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 23.3% during the forecast period. The growth of the single-use assemblies market can primarily be attributed to the major advantages of single-use technologies as compared to traditional stainless-steel assemblies,...
The Global Microbiome Partnering Terms and Agreements 2010 to 2021 report provides an understanding and access to the Microbiome partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Microbiome partnering deals Disclosed headlines, upfronts, milestones and royalties by...
The global single-use bioreactors market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption,...
306 pages •
By Global Industry Analysts
• May 2021
Global Cell Harvesting Market to Reach $359.2 Million by 2026
Cell harvesting is a next-generation technique that involves collection of stem cells from the culture media for R&D and therapeutic applications. Growth in the global market is spurred by of increasing investments...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
“Axial spondyloarthritis - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Axial spondyloarthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...
Global Cell Isolation Market By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue), By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation), By Application (Biomolecule...
The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.